Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

1.

Intestinal PTGS2 mRNA Levels, PTGS2 Gene Polymorphisms, and Colorectal Carcinogenesis.

Vogel LK, Sæbø M, Høyer H, Kopp TI, Vogel U, Godiksen S, Frenzel FB, Hamfjord J, Bowitz-Lothe IM, Johnson E, Kure EH, Andersen V.

PLoS One. 2014 Aug 28;9(8):e105254. doi: 10.1371/journal.pone.0105254. eCollection 2014.

PMID:
25166592
[PubMed - in process]
Free PMC Article
2.

Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines.

Wennerström AB, Lothe IM, Sandhu V, Kure EH, Myklebost O, Munthe E.

PLoS One. 2014 Aug 22;9(8):e103873. doi: 10.1371/journal.pone.0103873. eCollection 2014.

PMID:
25148029
[PubMed - in process]
Free PMC Article
3.

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab.

Kjersem JB, Skovlund E, Ikdahl T, Guren T, Kersten C, Dalsgaard AM, Yilmaz MK, Fokstuen T, Tveit KM, Kure EH.

BMC Cancer. 2014 May 19;14:340. doi: 10.1186/1471-2407-14-340.

PMID:
24884501
[PubMed - in process]
Free PMC Article
4.

Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study.

Tarpgaard LS, Guren TK, Glimelius B, Christensen IJ, Pfeiffer P, Kure EH, Sorbye H, Ikdahl T, Yilmaz M, Johansen JS, Tveit KM.

PLoS One. 2014 Feb 3;9(2):e87746. doi: 10.1371/journal.pone.0087746. eCollection 2014. Erratum in: PLoS One. 2014;9(5):e98836.

PMID:
24498368
[PubMed - in process]
Free PMC Article
5.

Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.

Kjersem JB, Ikdahl T, Lingjaerde OC, Guren T, Tveit KM, Kure EH.

Mol Oncol. 2014 Feb;8(1):59-67. doi: 10.1016/j.molonc.2013.09.001. Epub 2013 Sep 21.

PMID:
24119443
[PubMed - in process]
6.

Molecular responses to toxicological stressors: profiling microRNAs in wild Atlantic salmon (Salmo salar) exposed to acidic aluminum-rich water.

Kure EH, Sæbø M, Stangeland AM, Hamfjord J, Hytterød S, Heggenes J, Lydersen E.

Aquat Toxicol. 2013 Aug 15;138-139:98-104. doi: 10.1016/j.aquatox.2013.04.004. Epub 2013 Apr 24.

PMID:
23728355
[PubMed - indexed for MEDLINE]
Free Article
7.

Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.

Kjersem JB, Ikdahl T, Guren T, Skovlund E, Sorbye H, Hamfjord J, Pfeiffer P, Glimelius B, Kersten C, Solvang H, Tveit KM, Kure EH.

BMC Cancer. 2012 Nov 20;12:534. doi: 10.1186/1471-2407-12-534.

PMID:
23167843
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

KRAS mutational test for metastatic colorectal cancer patients: not just a technical problem.

Kure EH, Hamfjord J, Stangeland AM, Tveit KM, Ikdahl T.

Expert Rev Mol Diagn. 2012 May;12(4):327-8. doi: 10.1586/erm.12.29. No abstract available.

PMID:
22616697
[PubMed]
9.

Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing.

Hamfjord J, Stangeland AM, Hughes T, Skrede ML, Tveit KM, Ikdahl T, Kure EH.

PLoS One. 2012;7(4):e34150. doi: 10.1371/journal.pone.0034150. Epub 2012 Apr 17.

PMID:
22529906
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Wobble-enhanced ARMS method for detection of KRAS and BRAF mutations.

Hamfjord J, Stangeland AM, Skrede ML, Tveit KM, Ikdahl T, Kure EH.

Diagn Mol Pathol. 2011 Sep;20(3):158-65. doi: 10.1097/PDM.0b013e31820b49e2.

PMID:
21817902
[PubMed - indexed for MEDLINE]
11.

ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues.

Marcos NT, Bennett EP, Gomes J, Magalhaes A, Gomes C, David L, Dar I, Jeanneau C, DeFrees S, Krustrup D, Vogel LK, Kure EH, Burchell J, Taylor-Papadimitriou J, Clausen H, Mandel U, Reis CA.

Front Biosci (Elite Ed). 2011 Jun 1;3:1443-55.

PMID:
21622148
[PubMed - indexed for MEDLINE]
12.

The level of claudin-7 is reduced as an early event in colorectal carcinogenesis.

Bornholdt J, Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM, Johnson E, Kure EH, Vogel LK.

BMC Cancer. 2011 Feb 10;11:65. doi: 10.1186/1471-2407-11-65.

PMID:
21310043
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes.

Skjelbred CF, Svendsen M, Haugan V, Eek AK, Clausen KO, Kure EH, Tuimala JT, Svendsen MV, Norppa H, Hansteen IL.

Carcinogenesis. 2011 Mar;32(3):399-405. doi: 10.1093/carcin/bgq246. Epub 2010 Nov 19.

PMID:
21097530
[PubMed - indexed for MEDLINE]
Free Article
14.

Cytogenetic effects of exposure to 2.3 GHz radiofrequency radiation on human lymphocytes in vitro.

Hansteen IL, Clausen KO, Haugan V, Svendsen M, Svendsen MV, Eriksen JG, Skiaker R, Hauger E, Lågeide L, Vistnes AI, Kure EH.

Anticancer Res. 2009 Nov;29(11):4323-30.

PMID:
20032374
[PubMed - indexed for MEDLINE]
Free Article
15.

Cytogenetic effects of 18.0 and 16.5 GHz microwave radiation on human lymphocytes in vitro.

Hansteen IL, Lågeide L, Clausen KO, Haugan V, Svendsen M, Eriksen JG, Skiaker R, Hauger E, Vistnes AI, Kure EH.

Anticancer Res. 2009 Aug;29(8):2885-92.

PMID:
19661291
[PubMed - indexed for MEDLINE]
Free Article
16.

Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.

Selzer-Plon J, Bornholdt J, Friis S, Bisgaard HC, Lothe IM, Tveit KM, Kure EH, Vogel U, Vogel LK.

BMC Cancer. 2009 Jun 25;9:201. doi: 10.1186/1471-2407-9-201.

PMID:
19555470
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Collagen mRNA levels changes during colorectal cancer carcinogenesis.

Skovbjerg H, Anthonsen D, Lothe IM, Tveit KM, Kure EH, Vogel LK.

BMC Cancer. 2009 May 7;9:136. doi: 10.1186/1471-2407-9-136.

PMID:
19422682
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

CYP1A2 164 A-->C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas.

Saebø M, Skjelbred CF, Brekke Li K, Bowitz Lothe IM, Hagen PC, Johnsen E, Tveit KM, Kure EH.

Anticancer Res. 2008 Jul-Aug;28(4C):2289-95.

PMID:
18751408
[PubMed - indexed for MEDLINE]
Free Article
19.

Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas.

Skjelbred CF, Saebø M, Hjartåker A, Grotmol T, Hansteen IL, Tveit KM, Hoff G, Kure EH.

BMC Cancer. 2007 Dec 19;7:228.

PMID:
18093316
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma.

Lorentzen A, Vogel LK, Lewinsky RH, Saebø M, Skjelbred CF, Godiksen S, Hoff G, Tveit KM, Lothe IM, Ikdahl T, Kure EH, Mitchelmore C.

BMC Cancer. 2007 Oct 12;7:192.

PMID:
17935612
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk